Finally, to validate the association between STAG2, IRF9, and PD-L1 in clinical tumor samples, we analyzed skin cutaneous melanoma (SKCM) bulk RNA-seq data (n = 473 tumors) from the cancer genome atlas (TCGA)22. This evidence concerns the gene IRF9 and cutaneous melanoma.